Zurutuza L, Muller F, Gibrat J F, Taillandier A, Simon-Bouy B, Serre J L, Mornet E
Centre d'Etude de Biologie Prénatale--SESEP, Université de Versailles-Saint Quentin, Versailles, France.
Hum Mol Genet. 1999 Jun;8(6):1039-46. doi: 10.1093/hmg/8.6.1039.
Hypophosphatasia, a rare inherited disorder characterized by defective bone mineralization, is highly variable in its clinical expression. The disease is due to various mutations in the tissue-non-specific alkaline phosphatase ( TNSALP ) gene. We report here the use of clinical data, site-directed mutagenesis and computer-assisted modelling to propose a classification of 32 TNSALP gene mutations found in 23 European patients, 17 affected with lethal hypophosphatasia and six with non-lethal hypophosphatasia. Transfection studies of the missense mutations found in non-lethal hypophosphatasia showed that six of them allowed significant residual in vitro enzymatic activity, suggesting that these mutations corresponded to moderate alleles. Each of the six patients with non-lethal hypophosphatasia carried at least one of these alleles. The three-dimensional model study showed that moderate mutations were not found in the active site, and that most of the severe missense mutations were localized in crucial domains such as the active site, the vicinity of the active site and homodimer interface. Some mutations appeared to be organized in clusters on the surface of the molecule that may represent possible candidates for regions interacting with the C-terminal end involved in glycosylphosphatidylinositol (GPI) attachment or with other dimers to form tetramers. Finally, our results show a good correlation between clinical forms of the disease, mutagenesis experiments and the three-dimensional structure study, and allowed us to clearly distinguish moderate alleles from severe alleles. They also confirm that the extremely high phenotypic heterogeneity observed in patients with hypophosphatasia was due mainly to variable residual enzymatic activities allowed by missense mutations found in the human TNSALP gene.
低磷酸酯酶症是一种罕见的遗传性疾病,其特征为骨矿化缺陷,临床表现高度可变。该疾病是由组织非特异性碱性磷酸酶(TNSALP)基因的各种突变引起的。我们在此报告利用临床数据、定点诱变和计算机辅助建模,对在23名欧洲患者中发现的32种TNSALP基因突变进行分类,其中17名患有致死性低磷酸酯酶症,6名患有非致死性低磷酸酯酶症。对非致死性低磷酸酯酶症中发现的错义突变进行的转染研究表明,其中6种突变在体外具有显著的残余酶活性,这表明这些突变对应于中度等位基因。6名患有非致死性低磷酸酯酶症的患者每人至少携带其中一个等位基因。三维模型研究表明,活性位点未发现中度突变,大多数严重错义突变位于关键结构域,如活性位点、活性位点附近和同型二聚体界面。一些突变似乎在分子表面聚集成簇,这些区域可能是与参与糖基磷脂酰肌醇(GPI)附着的C末端或与其他二聚体相互作用形成四聚体的区域的潜在候选者。最后,我们的结果表明该疾病的临床形式、诱变实验和三维结构研究之间具有良好的相关性,并使我们能够清楚地区分中度等位基因和严重等位基因。它们还证实,低磷酸酯酶症患者中观察到的极高表型异质性主要是由于人类TNSALP基因中错义突变所允许的可变残余酶活性。